StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CCA.AX$0.07-1.43%
Fair $0.07+0.0%

CCA.AX

Change Financial Limited

Technology / Information Technology ServicesASX

$0.07

-0.00 (-1.43%)

Fairly Valued+0.0%Fair Value $0.07Fund rank 32/100 · Data gapFallback financials|
SA 21/D
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 25%

FCF escenarios

weak_data · normalized FCF $-2.6M · quality 79.0/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 45/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

21/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -43.7%, below the 5% threshold
Thesis & Journal · CCA.AXLocal privado en este navegador · Change Financial Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$48M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-43.7%

↓

Gross Margin

100.0%

↑

Debt/Equity

0.03

↓
52-Week Range$0
$0$0

TradingView lightweight chart

CCA.AX price, volumen y niveles de valoración

Último $0.069Periodo -84.2%
Fair value: $0.069

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

+19.7%

FCF CAGR

—

FCF margin

-22.7%

FCF / Net income

0.93x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $10.5M · net income $-2.6M · FCF $-2.4M

2021-FY → 2024-FY

Gross margin

100.0%+0.0% pts

Operating margin

-22.5%+25.7% pts

Net margin

-24.4%+32.3% pts

FCF margin

-22.7%+17.1% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$10.5M$10.5M$8.6M$8.2M$6.1M
Net Income$-2.6M$-2.6M$-2.9M$-3.8M$-3.5M
EBITDA$-621168.00$-621168.00$-1.3M$-2.5M$-2.3M
EPS-0.00-0.00-0.01-0.01-0.01
Gross Margin100.0%100.0%100.0%100.0%100.0%
Operating Margin-22.5%-22.5%-30.1%-46.2%-48.1%
Net Margin-24.4%-24.4%-33.8%-46.2%-56.7%
Balance Sheet
Debt/Equity0.030.030.020.390.08
Current Ratio1.111.11———
Cash Flow
Free Cash Flow$-2.4M$-2.4M$-2.6M$-3.3M$-2.4M
Returns
ROE-43.7%-43.7%-34.6%-112.7%-49.5%
Valuation
P/B7.377.372.987.125.23
Growth & Yield
Revenue Growth21.6%21.6%6.0%33.0%—
EPS Growth24.1%24.1%41.5%0.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -1.4%

Total return

-1.4%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.01 → -0.00

Residual

-1.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-1.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.